Sanofi-Aventis Acquisitions Could Double OTC Sales By 2014
This article was originally published in The Tan Sheet
Executive Summary
French drug maker Sanofi-Aventis is establishing an OTC division and plans to double revenues from nonprescription drug products within five years
You may also be interested in...
People In Brief
Colgate appoints new CFO
Sanofi Acquires BMP Sunstone To Expand Chinese Consumer Health Portfolio
Sanofi-Aventis gains a leadership position in China's OTC cough/cold market with its $520.6 million acquisition of BMP Sunstone, the latest in the global pharma's parade of consumer health buys.
Deals Of The Week: Sanofi, Teva, Ablexis; Kadmon Emerges From Stealth Mode
Each week, “The Pink Sheet” presents commentary on some of the week’s most interesting business deals, contributed by the editors of the IN VIVO blog. Visit the blog at http://invivoblog.blogspot.com.